Characterization of perceived validation need for digit

Summary of third Nordic symposium on digital pathology. Lundström C, Waltersson M, Persson A, Treanor D - J Pathol Inform (2016) Bottom Line: Cross-disciplinary and cross-sectorial collaboration is a key success factor for turning the promise of digital pathology into actual clinical benefits.This article is a summary of the third NDP symposium in Linkφping, Sweden.This summary also contains results from a survey on adoption and validation aspects of clinical digital pathology use. View Article: PubMed Central - PubMed Affiliation: Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden, UK. ABSTRACT Cross-disciplinary and cross-sectorial collaboration is a key success factor for turning the promise of digital pathology into actual clinical benefits. The Nordic symposium on digital pathology (NDP) was created to promote knowledge exchange in this area, among stakeholders in health care, industry, and academia. This article is a summary of the third NDP symposium in Linkφping, Sweden. The Nordic experiences, including several hospitals using whole-slide imaging for substantial parts of their primary reviews, formed a fertile base for discussions among the 190 NDP attendees originating from 15 different countries. This summary also contains results from a survey on adoption and validation aspects of clinical digital pathology use. No MeSH data available.	© Copyright Policy - open-access Related In: Results - Collection License Show All Figures getmorefigures.php?uid=PMC4837798&req=5 Figure 6: Characterization of perceived validation need for digital pathology. The majority sees further validation as a part of continued progress, but not as prohibitive for adoption in general Mentions: There is an ongoing debate in the community regarding what type or scale of validation that is needed before adoption of digital pathology in diagnosis. To elicit the overall opinion, the survey asked: “What's your personal view on the need for validation efforts to increase the confidence for digital pathology in clinical practice?” For this group having substantial experience of clinical use of WSI, the dominant view (68%) is that current knowledge is sufficient for going ahead with digital pathology adoption and that further validation is characterized as a continuous improvement effort. This may again reflect the high proportion of early adopters in the audience. As seen in Figure 6, about 20% are more hesitant and require further validation as a condition for adoption.

Summary of third Nordic symposium on digital pathology.

Lundström C, Waltersson M, Persson A, Treanor D - J Pathol Inform (2016)

Bottom Line: Cross-disciplinary and cross-sectorial collaboration is a key success factor for turning the promise of digital pathology into actual clinical benefits.This article is a summary of the third NDP symposium in Linkφping, Sweden.This summary also contains results from a survey on adoption and validation aspects of clinical digital pathology use.

View Article: PubMed Central - PubMed

Affiliation: Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden, UK.

ABSTRACT

Cross-disciplinary and cross-sectorial collaboration is a key success factor for turning the promise of digital pathology into actual clinical benefits. The Nordic symposium on digital pathology (NDP) was created to promote knowledge exchange in this area, among stakeholders in health care, industry, and academia. This article is a summary of the third NDP symposium in Linkφping, Sweden. The Nordic experiences, including several hospitals using whole-slide imaging for substantial parts of their primary reviews, formed a fertile base for discussions among the 190 NDP attendees originating from 15 different countries. This summary also contains results from a survey on adoption and validation aspects of clinical digital pathology use.

No MeSH data available.

Characterization of perceived validation need for digital pathology. The majority sees further validation as a part of continued progress, but not as prohibitive for adoption in general

Related In: Results - Collection

License

Show All Figures

getmorefigures.php?uid=PMC4837798&req=5

Figure 6: Characterization of perceived validation need for digital pathology. The majority sees further validation as a part of continued progress, but not as prohibitive for adoption in general

Mentions: There is an ongoing debate in the community regarding what type or scale of validation that is needed before adoption of digital pathology in diagnosis. To elicit the overall opinion, the survey asked: “What's your personal view on the need for validation efforts to increase the confidence for digital pathology in clinical practice?” For this group having substantial experience of clinical use of WSI, the dominant view (68%) is that current knowledge is sufficient for going ahead with digital pathology adoption and that further validation is characterized as a continuous improvement effort. This may again reflect the high proportion of early adopters in the audience. As seen in Figure 6, about 20% are more hesitant and require further validation as a condition for adoption.